Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality

FD Mast, AT Navare, AM van der Sloot… - Journal of Cell …, 2020 - rupress.org
With the rapid global spread of SARS-CoV-2, we have become acutely aware of the
inadequacies of our ability to respond to viral epidemics. Although disrupting the viral life …

Transcriptomic responses to antibiotic exposure in Mycobacterium tuberculosis

H Poonawala, Y Zhang, S Kuchibhotla… - Antimicrobial Agents …, 2024 - Am Soc Microbiol
Transcriptional responses in bacteria following antibiotic exposure offer insights into
antibiotic mechanism of action, bacterial responses, and characterization of antimicrobial …

The pursuit of mechanism of action: uncovering drug complexity in TB drug discovery

T Yuan, JM Werman, NS Sampson - RSC chemical biology, 2021 - pubs.rsc.org
Whole cell-based phenotypic screens have become the primary mode of hit generation in
tuberculosis (TB) drug discovery during the last two decades. Different drug screening …

Transcriptional regulator-induced phenotype screen reveals drug potentiators in Mycobacterium tuberculosis

S Ma, R Morrison, SJ Hobbs, V Soni… - Nature …, 2021 - nature.com
Transposon-based strategies provide a powerful and unbiased way to study the bacterial
stress response,,,,,,–, but these approaches cannot fully capture the complexities of network …

Tools to develop antibiotic combinations that target drug tolerance in Mycobacterium tuberculosis

T Greenstein, BB Aldridge - Frontiers in Cellular and Infection …, 2023 - frontiersin.org
Combination therapy is necessary to treat tuberculosis to decrease the rate of disease
relapse and prevent the acquisition of drug resistance, and shorter regimens are urgently …

Transcriptional adaptation of Mycobacterium tuberculosis that survives prolonged multi-drug treatment in mice

EA Wynn, C Dide-Agossou, M Reichlen… - Mbio, 2023 - Am Soc Microbiol
To address the ongoing global tuberculosis crisis, there is a need for shorter, more effective
treatments. A major reason why tuberculosis requires prolonged treatment is that, following …

Wollamide Cyclic Hexapeptides Synergize with Established and New Tuberculosis Antibiotics in Targeting Mycobacterium tuberculosis

RF Rollo, G Mori, TA Hill, D Hillemann… - Microbiology …, 2023 - Am Soc Microbiol
Shorter and more effective treatment regimens as well as new drugs are urgent priorities for
reducing the immense global burden of tuberculosis (TB). As treatment of TB currently …

[HTML][HTML] Integrative analysis of multimodal patient data identifies personalized predictors of tuberculosis treatment prognosis

A Sambarey, K Smith, C Chung, HS Arora, Z Yang… - Iscience, 2024 - cell.com
Summary Tuberculosis (TB) afflicted 10.6 million people in 2021, and its global burden is
increasing due to multidrug-resistant TB (MDR-TB) and extensively resistant TB (XDR-TB) …

Pre-clinical tools for predicting drug efficacy in treatment of tuberculosis

H Margaryan, DD Evangelopoulos, L Muraro Wildner… - Microorganisms, 2022 - mdpi.com
Combination therapy has, to some extent, been successful in limiting the emergence of drug-
resistant tuberculosis. Drug combinations achieve this advantage by simultaneously acting …

Early drug development and evaluation of putative antitubercular compounds in the-omics era

A Minias, L Żukowska, E Lechowicz, F Gąsior… - Frontiers in …, 2021 - frontiersin.org
Tuberculosis (TB) is an infectious disease caused by the bacterium Mycobacterium
tuberculosis. According to the WHO, the disease is one of the top 10 causes of death of …